XOMA Corp XOMA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:02 PM EDT
24.71UNCH (UNCH)
Volume
288
Close
24.71quote price arrow down-0.88 (-3.44%)
Volume
11,632
52 week range
13.48 - 27.00
Loading...
  • Open25.67
  • Day High26.29
  • Day Low24.71
  • Prev Close25.59
  • 52 Week High27.00
  • 52 Week High Date04/03/24
  • 52 Week Low13.48
  • 52 Week Low Date10/04/23

Key Stats

  • Market Cap287.501M
  • Shares Out11.64M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • YTD % Change33.57

KEY STATS

  • Open25.67
  • Day High26.29
  • Day Low24.71
  • Prev Close25.59
  • 52 Week High27.00
  • 52 Week High Date04/03/24
  • 52 Week Low13.48
  • 52 Week Low Date10/04/23
  • Market Cap287.501M
  • Shares Out11.64M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • YTD % Change33.57

RATIOS/PROFITABILITY

  • EPS (TTM)-3.92
  • P/E (TTM)-6.30
  • Fwd P/E (NTM)-9.19
  • EBITDA (TTM)-22.178M
  • ROE (TTM)-45.83%
  • Revenue (TTM)5.811M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-681.69%
  • Debt To Equity (MRQ)146.55%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On XOMA Corp

 

Profile

MORE
XOMA Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to larger pharmaceutical partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. Its royalty portfolio includes DAY101...
Jack Wyszomierski
Independent Chairman of the Board
Owen Hughes Jr.
Chief Executive Officer, Director
Thomas Burns
Chief Financial Officer, Senior Vice President - Finance
Address
Suite 310, 2200 Powell Street
Emeryville, CA
94608
United States

Top Peers

SYMBOLLASTCHG%CHG
PGEN
Precigen Inc
1.44+0.07+5.11%
OPT
Opthea Ltd
3.58-0.03-0.83%
VSTM
Verastem Inc
13.12-0.04-0.30%
VTYX
Ventyx Biosciences Inc
4.19+0.02+0.48%
INZY
Inozyme Pharma Inc
4.67+0.04+0.86%